Entheon Biomedical Corp.
Entheon Biomedical Corp.
CSE Index:
Currency:
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
Entheon Biomedical Corp. (ENBI)
SEDAR Information
Company Info
Address
Suite 720-999 W Broadway Street
Vancouver, BC V5Z 1K5
CanadaPhone
604-562-3932Email
info@entheonbiomedical.comWebsite
https://entheonbiomedical.com/Listing date
Thursday, May 3, 2018Transfer Agent
Olympia Trust CompanyAuditor
Manning Elliott LLPCapitalization
Issued & Outstanding:
59,089,266Reserved for Issuance:
4,275,000Company Officers
Timothy Ko, CEO
Soo-Whan Kim, Interim CFO
Kelly Pladson, Corporate Secretary
Andrew Hegle, Chief Science Officer
News Releases
Bulletins
11/11/2020
2020-1111 – Fundamental Change - MPV Explorations Inc./Entheon Biomedical Corp.
le 11 novembre/November 2020
Entheon Biomedical Corp., the issuer resulting from a Fundamental Change of MPV Explorations Inc. (MPV), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Advertisement
Publicité
Upcoming Events
Benzinga Cannabis Capital Conference
Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm
